Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice

Blood

Volumn 91, Issue 6, 1998, Pages 2045-2053

  Lijnen, H R ^a   Silence, J ^a   Van Hoef, B ^a   Collen, D ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; METALLOPROTEINASE; PLASMIN; STROMELYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY WALL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; EXTRACELLULAR MATRIX; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032521238     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.2045.2045_2045_2053     Document Type: Article

References (39)

1. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121, 1990
2. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145, 1991
3. Docherty AJ, Murphy G: The tissue metalloproteinase family and the inhibitor TIMP: A study using cDNAs and recombinant proteins. Ann Rheum Dis 49:469, 1990
4. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728, 1995
5. van Leeuwen RTJ: Extracellular proteolysis and the migrating vascular smooth muscle cell. Fibrinolysis 10:59, 1996
6. Murphy G: Matrix metalloproteinases and their inhibitors. Acta Orth Scand 66:55, 1995 (suppl 256)
7. He C, Wilhelm SM, Pentland AP, Manner BL, Grant GA, Eisen AZ, Goldberg GI: Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 86:2632, 1989
8. Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagase H: The activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29:10261, 1990
9. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ: The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann NY Acad Sci 667:1, 1992
10. Murphy G, Cocket MI, Stephens PE, Smith BJ, Doherty AJP: Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J 248:265, 1987
11. Ogata Y, Enghild JJ, Nagase H: Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267:3581, 1992
12. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T: Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 267:21712, 1992
13. Sasaguri Y, Kakita N, Murahashi N, Kato S, Hiraoka K, Morimatsu M, Yagi K: Effect of linoleic acid hydroperoxide on production of matrix metalloproteinases by human aortic endothelial and smooth muscle cells. Atherosclerosis 100:189, 1993
14. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S: Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 88:8154, 1991
15. Murphy G, Ward R, Hembry RM, Reynolds JJ, Kuhn K, Tryggvason K: Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J 258:463, 1989
16. Lyons JG, Birkedal-Hansen B, Moore WGI, O'Grady RL, Birkedal-Hansen H: Characteristics of a 95-kDa matrix metalloprotein-ase produced by mammary carcinoma cells. Biochemistry 30:1449, 1991
17. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H: Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 194:721, 1990
18. Chen JM, Aimes RT, Ward GR, Youngleib GL, Quigley JP: Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-transformed chicken embryo fibroblasts. J Biol Chem 266:5113, 1991
19. Moll UM, Youngleib GL, Rosinski KB, Quigley JP: Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res 50:6162, 1990
20. Mignatti P, Robbins E, Rifkin D: Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 47:487, 1986
21. Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC, Miskin R: Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48:3307, 1988
22. Mudgett JS, Hutchinson NI, Chartrain NA, Christen AJ, MacDonnel J, Singer II, Bayne EK, Flannagan J, Kawka D, Shen CF, Stevens K, Chen H, Trumbaruer M, Visco DM: Stromelysin-1 deficient mice and collagen induced arthritis susceptibility. Arth Rheum (submitted)
23. Giles AR: Guidelines for the use of animals in biomedical research. Thromb Haemost 58:1078, 1987
24. Lijnen HR, Van Hoef B, Beelen V, Collen D: Characterization of the murine plasma fibrinolytic system. Eur J Biochem 224:863, 1994
25. Lijnen HR, Van Hoef B, Collen D: Characterization of the murine plasminogen/ urokinase-type plasminogen activator system. Eur J Biochem 241:840, 1996
26. Carmeliet P, Moons L, Stassen JM, De Mol M, Bouché A, van den Oord JJ, Kockx M, Collen D: Vascular wound healing and neointima formation induced by perivascular electric injury in mice. Am J Pathol 150:761, 1997
27. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102:196, 1980
28. Kleiner DE, Stetler Stevenson WG: Quantitative zymography: Detection of picogram quantities of gelatinases. Anal Biochem 218:325, 1994
29. Carmeliet P, Moons L, Herbert J-M, Crawley J, Lupu F, Lijnen HR, Collen D: Urokinase-type but not tissue-type plasminogen activator mediates arterial neointima formation in mice. Circ Res 81:829, 1997
30. Lupu F, Heim DA, Bachmann F, Hurni M, Kakkar VV, Kruithof EKO: Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 15:1444, 1995
31. Lijnen HR, Wagner EF, Collen D: Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes. Thromb Haemost 77:362, 1997
32. Carmeliet P, Moons L, Ploplis V, Plow E, Collen D: Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J Clin Invest 99:200, 1997
33. Baramova EN, Bajou K, Remade A, L'Hoir C, Krell HW, Weidle UH, Noel A, Foidart JM: Involvement of PA/plasmin system in the processing of proMMP-9 and in the second step of proMMP-2 activation. FEBS Lett 405:157, 1997
34. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264:17213, 1989
35. Davis GE, Martin BM: A latent Mr 94,000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocytic leukemia cells: A member of the collagenase family of enzymes. Cancer Res 50:1113, 1990
36. Zempo N, Kenagy RD, Au YPT, Bendeck M, Clowes MM, Reidy MA, Clowes AW: Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J Vasc Surg 20:209, 1994
37. Lijnen HR, Van Hoef B, Vanlinthout I, Collen D: Plasminogen activator (PA) and matrix metalloproteinase (MMP) system function after vascular injury in mice with targeted inactivation of fibrinolytic genes. Thromb Haemost 377, 1997 (suppl, abstr 1539)
38. Carmeliet P, Collen D: Molecular analysis of blood vessel formation and disease. Am J Physiol 273:H2091, 1997
39. Lijnen HR, Silence J, Lemmens G, Collen D: Gelatinase activities in mice with targeted inactivation of plasminogen. Thromb Haemost 377, 1997 (suppl, abstr 2378)